Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Sargsyan, K; Macheiner, T; Story, P; Strahlhofer-Augsten, M; Plattner, K; Riegler, S; Granitz, G; Bayer, M; Huppertz, B.
Sustainability in Biobanking: Model of Biobank Graz.
Biopreserv Biobank. 2015; 13(6):410-420
Doi: 10.1089/bio.2015.0087
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Huppertz Berthold
-
Sargsyan Karine
- Co-Autor*innen der Med Uni Graz
-
Bayer Michaela
-
Hartl Gabriele
-
Macheiner Tanja
-
Riegler Skaiste
-
Strahlhofer-Augsten Manuela Herta
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Research infrastructures remain the key for state-of-the-art and successful research. In the last few decades, biobanks have become increasingly important in this field through standardization of biospecimen processing, sample storage, and standardized data management. Research infrastructure in cohort studies and other sample collection activities are currently experiencing a lack of long-term funding. In this article, the Biobank Graz discusses these aspects of sustainability including the definition of sustainability and necessity of a business plan, as well as cost calculation model in the field of biobanking. The economic state, critical success factors, and important operational issues are reviewed and described by the authors, using the example of the Biobank Graz. Sustainability in the field of biobanking is a globally important matter of necessity, starting from policy making and ending with security and documentation on each operational level.
- Find related publications in this database (using NLM MeSH Indexing)
-
Biological Specimen Banks - economics
-
Biological Specimen Banks - organization & administration
-
Biomedical Research -
-
Databases, Factual -
-
Financial Management -
-
Specimen Handling - economics
-
Specimen Handling - standards